North Country Regional Economic Development Council

"New Era for New York" Agenda Includes 228 Bold Initiatives to Kick-Start New York's Comeback

$10 Billion Healthcare Plan Will Rebuild and Grow Workforce, Deliver Direct Payments to Workers

Major Ethics Reforms Will Limit Statewide Elected Officials to Two Terms, Ban Outside Income and Replace JCOPE with New Independent Ethics Agency

Billion Dollar Rescue Plan Will Help Small Businesses Come Back, Middle Class Tax Relief Will Lift Up Millions of New Yorkers

Infrastructure Investments Will Expand Transit in New York City and Lead the Nation in Climate Action

State of the State Book Available Here

Awards Support 488 Projects from Multiple State Agency Programs through Round XI to Stimulate New York's Post-Pandemic Recovery 

Complements $81 Million in Rolling Empire State Development Funding Previously Awarded to Shovel-Ready Regional Projects 

Full List of Awardees Can be Found Here

Governor Hochul Announces Expanded Eligibility for the $800 Million COVID-19 Pandemic Small Business Recovery Grant Program

Governor Kathy Hochul announced changes to New York State's $800 million COVID-19 Pandemic Small Business Recovery Grant Program that will enable more small businesses to apply for funding. Starting today, businesses with revenues up to $2.5 million can apply for grants, up from the previous threshold of $500,000. Additionally, the limitation for businesses that received Federal Paycheck Protection Program loans has been increased from $100,000 to $250,000.   

Applicants can find assistance to complete the application here:  https://nysmallbusinessrecovery.com/partners/county/

Click Here for more information on New York State's Business Recovery Programs

The deadline has been extended for the short form applications to the Biodefense Commercialization Fund from September 27 to October 4.

The $40 million Biodefense Commercialization Fund, which was included in the FY2022 budget, was created to encourage and accelerate the development and commercialization of solutions for serious infectious disease threats, including COVID-19 and its variants, while fostering the creation of new life science businesses and supporting industry growth. The Fund offers grants to startups and academic centers that are developing promising diagnostics, vaccines, therapeutics, and such other innovations as epidemiological surveillance tools, environmental controls, and clinical care advances that address or mitigate infectious disease threats.